Newsfile Corp
29 Jun 2026, 23:27 UTC · 11w ago
Verdict
Headline takes no side. We score IMMP −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The Independent Data Monitoring Committee recommended the discontinuation of Immutep's Phase III TACTI-004 study for futility.
So whatThe failure of a late-stage clinical trial for a lead drug candidate typically results in a massive loss of company valuation and future revenue prospects.
More negative than 99% of claims this week
A class action lawsuit has been filed alleging that Immutep misled investors regarding the viability and efficacy of its drug candidate.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 80% of claims this week
Immutep's ADR price collapsed approximately 83% from $2.76 to $0.48 following the futility announcement.
So whatWhile the price drop has already occurred, it confirms the market's severe devaluation of the company's current pipeline.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit and a massive stock price drop following the discontinuation of a Phase III clinical trial for futility.
More negative than 87% of ticker scores this week
The company is being urged by a law firm for stockholders to move for lead plaintiff, indicating ongoing shareholder litigation.
More negative than 87% of ticker scores this week
The company is being urged by a law firm for stockholders to move for lead plaintiff, indicating ongoing shareholder litigation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
4h ago
−19.4%
Price agrees with the score
$0.3287 vs $0.4076 close before publication (Jun 29) · not market-adjusted
IMMP chart →
